5 Best Hemp Stocks To Buy Now

Page 5 of 5

1. Tilray Brands, Inc. (NASDAQ:TLRY)

On April 22, Bloomberg reported, citing an on-air discussion with CEO Irwin Simon, that Tilray Brands, Inc. (NASDAQ:TLRY) shares rose by around 10% after surging as much as 18% earlier, amid strong trading activity of more than 20 million shares. He said the move shows interest in a potential cannabis reclassification, stressing that it is important “for patients” and the larger business, not just the corporation. He noted that the corporation distributes cannabis in over 21 countries, producing more than $100 million globally and $200 million in Canada, as well as conducts research into medical applications such as cancer and epilepsy.

As per the CEO, Tilray Brands, Inc. (NASDAQ:TLRY) does not currently sell cannabis in the United States, explaining that the company has instead grown into beer and beverages. He said that reclassification would help collaboration with the FDA, using current research for approvals addressing medical conditions. Entering the US market could happen “within six months” if licenses are granted, he said, calling the prospect “tremendous” given the firm’s infrastructure and global experience.

Tilray Brands, Inc. (NASDAQ:TLRY) is a consumer packaged goods firm. It focuses on medical cannabis research and the cultivation, processing, and global distribution of cannabis products. It operates in the cannabis, distribution, beverage, and wellness segments.

While we acknowledge the potential of TLRY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TLRY and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 20 Best Performing Stocks in 2025 and 12 Best Food Stocks to Buy in 2026.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 5 of 5